Pemphigus: Active or inactive?

Indian Journal of Dermatology

Volumn 54, Issue 2, 2009, Pages 186-188

  Vaishnani, Jignesh ^a   Bosamiya, Sanjay ^a  

^a Surat Municipal Institute of Medical Education & Research   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; DESMOGLEIN 1; DESMOGLEIN 3; DEXAMETHASONE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; STEROID;

DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; LETTER; MOUTH LESION; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PRURITUS; REMISSION; SCORING SYSTEM; TOXEMIA;

EID: 68049121882     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.53173     Document Type: Letter

References (26)

1. Lapidoth M, David M, Ben-Amitai D, Katzenelson V, Lustig S, Sandbank M. The efficacy of combine treatment with prednisolon and cyclophosphamide in patient with Pemphigus. J Am Acad Dermatol 1994;30:752-7.
2. Ratnam KV, Brayank P. Pemphigus in remission: Value of negative direct immunofluorescence in management. J Am Acad Dermatol 1994;30:547-50.
3. Ryan JG. Pemphigus: A 20 year survey of experience with 70 cases. Arch Dermatol 1971;104:14-20.
4. Rusenberg FR, Sanders S, Nelsion CT. Pemphigus: A 20 year review of 107 patients treated with steroid. Arch Dermatol 1976;112:962-70.
5. Ratnam KV, Phay KL, Tan CK. Pemphigus therapy with oral prednisolon regimes: A 5 years study. Int J Dermatol 1990;29:363-7.
6. Korman N. Pemphigus. J Am Acad Dermatol 1988;18:1219-38.
7. Salopek TG. Nikolsky.s sign: Dry or wet? Br J Dermatol 1997;136:762-7.
8. Hameed A, Khan AA. Microscopic Nikolsky's sign. Clin Exp Dermatol 1999;24:312-4.
9. Seidenbaum M, David M, Sandbank M. The course and prognosis of Pemphigus: A review of 115 patients. Int J Dermatol 1988;27:580-4.
10. Fernandes JC, Dharan JB. Study of 100 cases of Pemphigus. Indian J Dermatol Venerol Leprol 1970;36:1-11.
11. Pavithran K. Exuberant granulation in the oral cavity in Pemphigus vegetans. Indian J Dermatol Venerol Leprol 1988;54:305-6.
12. Yesudian PD, Krishna S, Jayaraman M, Janki V, Yesudian P. Post Pemphigus acanthomata: A sign of clinical activity. Int J Dermatol 1997;36:194-6.
13. Agrawal M, Walia R, Kochar AM, Chander R. "PAAS" a novel clinical scoring method for monitoring of pemphigus vulgaris patients. Int J Dermatol 1998;37:158-9.
14. Agarwal S, Kalla G, Khullar R, Khare AK, Ahmed K. Pruritus and activity of pemphigus vulgaris. Indian J Dermatol 1992;37:13-4.
15. Arya SR, Valand AG, Krishna K. A clinico-pathological study of 70 cases of pemphigus. Indian J Dermatol Venereol Leprol 1999;65:168-71.
16. Judd KP, Lever WF. Correlation of antibody in the skin and serum with disease severity in Pemphigus. Arch Dermatol 1979;115:428-32.
17. David M, Weissman-Katzenelson V, Ben-Chetrit A, Hazaz B, Ingber A, Sandbank M. The usefulness of IIF in Pemphigus patients in clinical remission. Br J Dermatol 1989;120:391-5.
18. Krain LS. Pemphigus epidemiological survey of 59 patients from 1955-1973. Arch Dermatol 1974;110:862-5.
19. Harman KE, Seed PT, Gratian MJ, Bhogal BS, Challacombe SJ, Black MM. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol 2001;144:775-80.
20. Beutner EH, Chorzelski TP, Jablonska S. Immunofluorescence tests: Clinical significance of sera and skin in bullous diseases. Int J Dermatol 1985;24:405-21.
21. Seith J, Kanwar AJ, Kaur S. DIF as a diagnostic and prognostic marker in Pemphigus. Indian J Dermatol Venerol Leprol 1992;58:379-83.
22. Lenz PA, Amagai M, Beatrix VP, Georg S, Kirnbauer R. Desmoglein-3 ELISA: A Pemphigus vulgaris specific test. Arch Dermatol 1999;135:143-8.
23. Komai A, Amagai M. The clinical transition between Pemphigus foliaceous and Pemphigus vulgaris correlates well with the change in autoantibody profile assessed by an enzyme linked immunosorbant assay. Br J Dermatol 2001;144:1177-82.
24. Harman EK, Gratian MJ, Bhopal BS, Challacombe SJ, Black MM. A study of desmoglein-1 autoantibodies in Pemphigus vulgaris: Racial differences in frequency and the association with a more severe phenotype. Br J Dermatol 2000;143:343-8.
25. Nguyen VT, Lee T. The pathophysiological significance of nondesmoglein target of pemphigus autoantobodies. Arch Dermatol 1998;134:971-80.
26. Sulochana G, Manivannum SM, Padmanabban L. The value of serum beta glucuronidase in assessing response to therapy for Pemphigus. Indian J Dermatol Venerol Leprol 1982;48:348-55.